Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Revenues:        
License and collaborative fees $ 2,525 $ 6,039 $ 3,538 $ 11,866
Contract and other 6,181 10,486 15,026 20,254
Product sales 569 0 576 0
Total revenues 9,275 16,525 19,140 32,120
Operating expenses:        
Research and development 18,441 18,281 34,211 35,628
Selling, general and administrative 3,567 6,113 8,246 11,483
Restructuring 676 0 4,453 0
Cost of sales 81 0 82 0
Total operating expenses 22,765 24,394 46,992 47,111
Loss from operations (13,490) (7,869) (27,852) (14,991)
Other income (expense):        
Interest expense (1,025) (634) (2,068) (1,166)
Other income (expense) 542 (86) (122) (1,144)
Revaluation of contingent warrant liabilities (2,182) 459 (16,538) 2,850
Net loss before taxes (16,155) (8,130) (46,580) (14,451)
Provision for income tax expense 0 0 0 (15)
Net loss (16,155) (8,130) (46,580) (14,466)
Basic and diluted net loss per common stock (in dollars per share) $ (0.24) $ (0.27) $ (0.83) $ (0.49)
Shares used in computing basic and diluted net loss per share of common stock (in shares) 68,087 29,889 56,221 29,536
Other comprehensive loss:        
Comprehensive loss $ (16,150) $ (8,129) $ (46,575) $ (14,465)